Corrigendum: Highly invasive fluorescent/bioluminescent patient-derived orthotopic model of glioblastoma in mice

Diana Yuzhakova; Elena Kiseleva; Marina Shirmanova; Vladislav Shcheslavskiy; Daria Sachkova; Ludmila Snopova; Evgeniya Bederina; Maria Lukina; Varvara Dudenkova; Gaukhar Yusubalieva; Tatyana Belovezhets; Daria Matvienko; Vladimir Baklaushev

doi:10.3389/fonc.2022.1040637

Corrigendum: Highly invasive fluorescent/bioluminescent patient-derived orthotopic model of glioblastoma in mice

Front Oncol. 2022 Sep 29:12:1040637. doi: 10.3389/fonc.2022.1040637. eCollection 2022.

Authors

Diana Yuzhakova¹, Elena Kiseleva¹, Marina Shirmanova¹, Vladislav Shcheslavskiy^{1

2}, Daria Sachkova^{1

3}, Ludmila Snopova¹, Evgeniya Bederina¹, Maria Lukina^{1

4}, Varvara Dudenkova¹, Gaukhar Yusubalieva^{5

6}, Tatyana Belovezhets⁷, Daria Matvienko⁷, Vladimir Baklaushev^{5

6}

Affiliations

¹ Institute of Experimental Oncology and Biomedical Technologies, Privolzhsky Research Medical University, Nizhny Novgorod, Russia.
² R&D Department, Becker&Hickl GmbH, Berlin, Germany.
³ Institute of Biology and Biomedicine, Lobachevsky State University of Nizhny Novgorod, Nizhny Novgorod, Russia.
⁴ Laboratory of Molecular Oncology, Federal Research and Clinical Center of Physical and Chemical Medicine, Moscow, Russia.
⁵ Biomedical Research Center, Federal Research and Clinical Center, Federal Medical and Biological Agency, Moscow, Russia.
⁶ Laboratory of Molecular Mechanisms of Regeneration and Aging, Engelhardt Institute of Molecular Biology, Moscow, Russia.
⁷ Department of Molecular Immunology, Institute of Molecular and Cellular Biology SB RAS, Novosibirsk, Russia.

Abstract

[This corrects the article DOI: 10.3389/fonc.2022.897839.].

Keywords: FLIM (fluorescence lifetime imaging microscopy); fluorescence imaging; glioblastoma (GBM); patient-derived xenograft (PDX); primary cell line.

Publication types

Published Erratum